Call us
07971549402




Price:
Price 120.80625 INR / Vial
Minimum Order Quantity : 100 Vials
Packaging Type : Glass Vial with Carton
Brand Name : Levetiracetam Injection 100 mg
Drug Type : Other, Prescription Allopathic
Ingredients : Levetiracetam 100mg
Price 470.0 INR / Vial
Minimum Order Quantity : 100 Vials
Packaging Type : 1*40MG PFS
Brand Name : Enoxoark PFS 40
Drug Type : Injection
Ingredients : Enoxaparin Sodium 40mg Injection PFS is a low molecular weight heparin anticoagulant (4000 IU antiXa activity/0.4 mL) in a safetyengineered prefilled syringe for subcutaneous selfadministration. It primarily prevents venous thromboembolism (VTE) in moderatehigh risk surgical patients (orthopedic/general surgery, cancer surgery), medical patients (heart failure, immobility), and acute coronary syndromes when combined with aspirin; inhibits factor Xa > thrombin (IIa).
Price 257.0 INR / Vial
Minimum Order Quantity : 100 Vials
Packaging Type : 1*4 ml AMP
Brand Name : Clinark600
Drug Type : Injection
Ingredients : Clindamycin Injection IP 4 mL is a sterile solution ampoule containing 600 mg clindamycin phosphate (150 mg/mL concentration) for IM/IV administration. The lincosamide antibiotic inhibits bacterial protein synthesis at the 50S ribosomal subunit, treating serious anaerobic infections (Bacteroides fragilis, Clostridium), skin/soft tissue infections, pneumonia, intraabdominal sepsis, bone/joint infections, and endocarditis; penetrates well into bone and abscesses.
Price 1125.0 INR / Number
Minimum Order Quantity : 100
Packaging Type : 10*15 Blister
Brand Name : GLIMLASEMV1
Drug Type : Other
Ingredients : Metformin (SR) 500 mg + Voglibose 0.2 mg + Glimepiride 1 mg Bilayered Tablet is a triple fixeddose combination for type 2 diabetes that integrates sustainedrelease metformin (hepatic gluconeogenesis suppression), glimepiride (pancreatic insulin secretion stimulation), and voglibose (alphaglucosidase inhibition to blunt postprandial glucose spikes). This synergistic bilayer formulation provides comprehensive glycemic control (HbA1c 2.02.5%) targeting fasting, postprandial glucose, and glycemic variability, particularly effective in Indian patients with high postprandial excursions; CDSCOapproved FDC reduces pill burden while managing the "glycemic hexad." Adults: 1 tablet once daily before meals; side effects include hypoglycemia (1015%), flatulence/abdominal discomfort (vogliboserelated), GI upset (less with SR), weightneutral; contraindicated in DKA, eGFR<30 mL/min; monitor HbA1c quarterly, renal function.